![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2-acetamidofluorene | increases expression | ISO | RGD:2325377 | 6480464 | 2-Acetylaminofluorene results in increased expression of MIR205 mRNA | CTD | PMID:19167416 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MIR205 mRNA | CTD | PMID:30851411 | 3-chloropropane-1,2-diol | increases expression | ISO | RGD:1607684 | 6480464 | alpha-Chlorohydrin analog results in increased expression of MIR205 mRNA | CTD | PMID:29860048 | aflatoxin B1 | increases expression | ISO | RGD:2325377 | 6480464 | Aflatoxin B1 results in increased expression of MIR205 mRNA | CTD | PMID:24472605 | amphetamine | increases expression | ISO | RGD:2325377 | 6480464 | Amphetamine results in increased expression of MIR205 mRNA | CTD | PMID:30779732 | arsane | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of MIR205 mRNA | CTD | PMID:25586904 | arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of MIR205 mRNA | CTD | PMID:25586904 | atrazine | decreases expression | ISO | RGD:2325377 | 6480464 | Atrazine results in decreased expression of MIR205 mRNA | CTD | PMID:31185338 | benzene | decreases expression | ISO | RGD:1607684 | 6480464 | Benzene results in decreased expression of MIR205 mRNA | CTD | PMID:32105654 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MIR205 mRNA | CTD | PMID:28238728 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MIR205 mRNA | CTD | PMID:27510461 | cadmium dichloride | multiple interactions | EXP | | 6480464 | KRAS protein inhibits the reaction [Cadmium Chloride results in decreased expression of MIR205 mRNA] | CTD | PMID:27510461 | chloropicrin | decreases expression | EXP | | 6480464 | chloropicrin results in decreased expression of MIR205 mRNA | CTD | PMID:26352163 | cisplatin | affects response to substance | EXP | | 6480464 | MIR205 promoter affects the susceptibility to Cisplatin | CTD | PMID:20099276 | cisplatin | increases response to substance | EXP | | 6480464 | MIR205 mRNA results in increased susceptibility to Cisplatin | CTD | PMID:29464002 | cisplatin | multiple interactions | EXP | | 6480464 | [MIR205 mRNA results in increased susceptibility to Cisplatin] which results in decreased expression of BCL2 protein more ... | CTD | PMID:29464002 | cisplatin | decreases expression | ISO | RGD:2325377 | 6480464 | Cisplatin results in decreased expression of MIR205 mRNA | CTD | PMID:27397436 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of MIR205 | CTD | PMID:30923833 | copper atom | multiple interactions | EXP | | 6480464 | [Copper results in increased expression of MIR205] which results in decreased expression of LRP1 mRNA | CTD | PMID:30923833 | copper(0) | multiple interactions | EXP | | 6480464 | [Copper results in increased expression of MIR205] which results in decreased expression of LRP1 mRNA | CTD | PMID:30923833 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of MIR205 | CTD | PMID:30923833 | dexamethasone | increases expression | ISO | RGD:1607684 | 6480464 | Dexamethasone results in increased expression of MIR205 mRNA | CTD | PMID:22110677 | icariin | increases expression | ISO | RGD:1607684 | 6480464 | icariin results in increased expression of MIR205 mRNA | CTD | PMID:30533443 | lipopolysaccharide | increases expression | ISO | RGD:1607684 | 6480464 | Lipopolysaccharides results in increased expression of MIR205 mRNA | CTD | PMID:22110677 | nitrogen dioxide | multiple interactions | ISO | RGD:1607684 | 6480464 | [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR205 mRNA | CTD | PMID:30090456 | paracetamol | decreases expression | ISO | RGD:1607684 | 6480464 | Acetaminophen results in decreased expression of MIR205 mRNA | CTD | PMID:19246379 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of MIR205 mRNA | CTD | PMID:28619522 | potassium bromate | decreases expression | EXP | | 6480464 | potassium bromate results in decreased expression of MIR205 mRNA | CTD | PMID:30559759 | propiconazole | decreases expression | ISO | RGD:1607684 | 6480464 | propiconazole results in decreased expression of MIR205 mRNA | CTD | PMID:20175128 | quercetin | decreases expression | ISO | RGD:2325377 | 6480464 | Quercetin results in decreased expression of MIR205 mRNA | CTD | PMID:26432773 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MIR205 mRNA | CTD | PMID:30851411 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MIR205 mRNA | CTD | PMID:20637737 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIR205 mRNA | CTD | PMID:24431212 | sodium arsenite | increases expression | ISO | RGD:1607684 | 6480464 | sodium arsenite results in increased expression of MIR205 mRNA | CTD | PMID:24896083, PMID:32068019 | sodium arsenite | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [sodium arsenite results in decreased expression of MIR205 mRNA] | CTD | PMID:21292642 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of MIR205 mRNA | CTD | PMID:27054085 | sodium dodecyl sulfate | decreases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of MIR205 mRNA | CTD | PMID:31734321 | streptozocin | increases expression | ISO | RGD:1607684 | 6480464 | Streptozocin results in increased expression of MIR205 mRNA | CTD | PMID:27629361 | sulfur dioxide | multiple interactions | ISO | RGD:1607684 | 6480464 | [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR205 mRNA | CTD | PMID:30090456 | tetrachloromethane | decreases expression | ISO | RGD:2325377 | 6480464 | Carbon Tetrachloride results in decreased expression of MIR205 mRNA | CTD | PMID:27397436 | triadimefon | decreases expression | ISO | RGD:1607684 | 6480464 | triadimefon results in decreased expression of MIR205 mRNA | CTD | PMID:20175128 | zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MIR205 mRNA | CTD | PMID:22171008 | zinc atom | decreases expression | ISO | RGD:2325377 | 6480464 | Zinc deficiency results in decreased expression of MIR205 mRNA | CTD | PMID:22689922 | zinc atom | increases expression | ISO | RGD:2325377 | 6480464 | Zinc deficiency results in increased expression of MIR205 mRNA | CTD | PMID:22689922 | zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MIR205 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | ISO | RGD:2325377 | 6480464 | Zinc deficiency results in decreased expression of MIR205 mRNA | CTD | PMID:22689922 | zinc(0) | increases expression | ISO | RGD:2325377 | 6480464 | Zinc deficiency results in increased expression of MIR205 mRNA | CTD | PMID:22689922 | |